Sunnyvale, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces an allergy testing agreement with Northern California healthcare leader Sutter Health. The company is providing its proprietary microarray-based finger stick allergy testing services to Sutter Health via doctors in the Sutter Health-affiliated Palo Alto Medical Foundation. Sutter Health, one of the nation’s largest healthcare networks, is headquartered in Sacramento California and has 50,000 employees including 12,000 physicians and 14,000 nurses serving 3 million Northern California patients. Sutter Health draws 19% of its revenue from the California Medical Assistance Program (Medi-Cal) and reports total patient service revenues of $12,000,000,000 ($12 billion) annually.

Arrayit recently completed an allergy testing pilot program for a top retail chain, established a nationwide network of 1,700 allergy sales professionals, met with top officials at the United States Food and Drug Administration (FDA) regarding approval of a major product line, signed allergy testing contracts with a consortium of 178 medical clinics, received approval for in-store promotions by a major retailer, announced allergy testing partnerships with major allergy therapeutics providers, received approval for direct Medicare billing by the Centers for Medicare and Medicaid Services (CMS), reported the sale and shipping of clinical instrumentation to the FDA, aced three consecutive rounds of proficiency testing with the College of American Pathologists, launched the Patient Data Solutions allergy portal for doctors and clinics, celebrated 25 years of company operations and announced allergy test brands expansion. The agreement with Sutter Health significantly expands the company’s allergy testing bandwidth to include a major healthcare provider.

Chief Executive Officer Rene Schena states, “Partnering with healthcare leader Sutter Health fits perfectly within our mission of providing the most advanced allergy testing services available to our diverse Northern California healthcare community. Sutter’s focus on technological innovation, electronic medical records advances and telemedicine are highly synergistic with our physician-prescribed non-invasive finger stick microarray tests for allergy and other health and wellness indications.”

About Arrayit
Arrayit Corporation, headquartered in Sunnyvale, California, leads and empowers the research, biotechnology, pharmaceutical, clinical and healthcare sectors through the discovery, development and manufacture of proprietary life science and personalized medicine products and services to advance biomedical research and improve wellness and human health.  Please visit www.arrayit.com for more information.

Safe Harbor Statement
We have identified forward-looking statements by using words such as "expect", "believe", and "should". Although we believe our expectations are reasonable, our operations involve a number of risks and uncertainties that are beyond our control, and these statements may turn out not to be true. Risk factors associated with our business, including some of the facts set forth herein, are detailed in the Company's public filings.

CONTACT
Public Relations
Arrayit Corporation
Tel: 408-744-1331
Email: arrayit@arrayit.com
Web: www.arrayit.com

Public Relations
Arrayit Corporation
Tel: 408-744-1331
Email: arrayit@arrayit.com
Web: www.arrayit.com

Arrayit-Corporation-Logo.jpg

Arrayit (CE) (USOTC:ARYC)
Historical Stock Chart
From Sep 2024 to Oct 2024 Click Here for more Arrayit (CE) Charts.
Arrayit (CE) (USOTC:ARYC)
Historical Stock Chart
From Oct 2023 to Oct 2024 Click Here for more Arrayit (CE) Charts.